← NovaBridge Biosciences
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | — | $858k |
$53.8m
+6168.18%
|
$4.3m
-91.99%
|
$236.4m
+5386.75%
|
$13.8m
-94.16%
|
($32.1m)
-332.56%
|
$632k
+101.97%
|
$8.8m
+1290.19%
|
$7.6m
-13.37%
|
$0
-100.00%
|
|
| Cost of Goods and Services Sold | — | $453k |
$28.4m
+6168.18%
|
$2.3m
-91.99%
|
$124.7m
+5386.75%
|
$7.3m
-94.16%
|
$3.9m
-45.80%
|
$2.1m
-48.00%
|
$3.9m
+92.29%
|
$4.0m
+1.67%
|
$73.7m
+1735.02%
|
|
| Cost Of Revenue | — | — | — | — | — | $7.3m |
$3.9m
-45.81%
|
$0
-100.00%
|
— | — | $73.7m | |
| Gross Profit | — | $405k |
$25.4m
+6168.18%
|
$2.0m
-91.99%
|
$111.7m
+5386.75%
|
$6.5m
-94.16%
|
($36.1m)
-652.63%
|
$3.9m
+110.81%
|
$3.5m
-9.29%
|
$3.6m
+1.67%
|
$48.4m
+1246.90%
|
|
| Gross Profit (Calculated) | — | $405k |
$25.4m
+6168.18%
|
$2.0m
-91.99%
|
$111.7m
+5386.75%
|
$6.5m
-94.16%
|
($36.1m)
-652.67%
|
$1.8m
+105.10%
|
$3.5m
+92.29%
|
$3.6m
+1.67%
|
— | |
| Research And Development | — | — | $426.0m | $120.7m | $150.9m | $190.3m | $131.2m | $114.2m | $21.8m | $62.9m | $62.9m | |
| Research and development expenses (including amounts with related parties of $47,071, $0, and $0, respectively) | — | ($267.1m) | ($426.0m) | ($840.4m) | ($984.7m) | ($1.2b) | ($904.9m) | ($810.6m) | ($21.8m) | ($62.9m) | $62.9m | |
| General and Administrative Expense | — | — | $66.4m | $94.0m | $61.7m | $141.2m | $118.3m | $63.8m | $29.7m | $31.4m | $31.4m | |
| Amortization of Intangible Assets | — | — | — | — | $238k | $122k | $113k | $110k | — | — | — | |
| Operating Expenses | — | — | — | — | — | — | — | — | $51.4m | $94.3m | $94.3m | |
| Loss from operations | — | ($281.0m) |
($438.6m)
-56.12%
|
($1.5b)
-233.98%
|
— | ($2.1b) |
($2.0b)
+4.92%
|
($1.4b)
+28.99%
|
($51.4m)
+96.32%
|
($94.3m)
-83.31%
|
— | |
| Loss from operations of discontinued operations | — | — | — | — | — | — | ($229.8m) | ($125.5m) | ($6.9m) | — | — | |
| Other Non Operating Income Expenses | — | — | — | — | — | — | — | — | $637k | $74k | — | |
| Operating Income (Loss) | — | — | ($401.1m) |
($208.6m)
+48.00%
|
$74.0m
+135.50%
|
($366.4m)
-594.79%
|
($363.4m)
+0.80%
|
($206.4m)
+43.20%
|
($51.4m)
+75.09%
|
($94.3m)
-83.31%
|
($94.3m)
0.00%
|
|
| Interest Expense | — | — | $11.7m | $430k | $147k | $0 | $1k | $102k | — | — | — | |
| Interest Expense, Debt | — | — | $7.0m | — | — | — | — | — | — | — | — | |
| Interest Expense Non Operating | — | — | — | — | — | $0 | $1k | $102k | — | — | — | |
| Interest income | — | $858k | $4.6m | $30.6m | $24.2m | $21.3m | $26.9m | $51.7m | $7.5m | $7.6m | $7.6m | |
| Foreign Currency Transaction Gain (Loss), before Tax | — | — | $742k | $233k | ($3.4m) | $4.0m | ($25.4m) | ($8.6m) | ($5.6m) | ($4k) | — | |
| Gain on sale of discontinued operations | — | — | — | — | — | — | — | — | $34.4m | $34.4m | — | |
| Gain (loss) from discontinued operations | — | — | — | — | — | — | ($229.8m) | ($125.5m) | $27.5m | $0 | — | |
| Unrealized gain (loss) on available-for-sale debt securities, net of tax | — | — | — | — | — | — | — | — | ($8.2m) | $11.6m | — | |
| Gain On Sale Of Business | — | — | — | — | — | $0 | $0 | ($1.1m) | — | — | — | |
| Gain On Sale Of Security | — | — | — | — | — | — | — | — | $8.3m | ($1.8m) | ($1.8m) | |
| Net gain (loss) per share from discontinued operations - basic | — | — | — | — | — | — | ($1.22) | ($0.66) | $0.15 | $0.00 | — | |
| Net gain (loss) per share from discontinued operations - diluted | — | — | — | — | — | — | ($1.22) | ($0.66) | $0.15 | $0.00 | — | |
| Income (Loss) from Equity Method Investments | — | — | — | — | ($16.6m) | ($57.7m) | ($63.4m) | ($11.3m) | ($1.0m) | — | — | |
| Other Income | — | — | — | — | $2.3m | $2.4m | $2.8m | $8.6m | $1.3m | — | — | |
| Other Nonoperating Income (Expense) | — | — | ($16.8m) | ($2.9m) | $63.3m | $13.1m | ($18.4m) | ($5.4m) | ($4.7m) | ($1.7m) | — | |
| Other expenses, net | — | $1.5m | ($16.8m) | ($20.2m) | $412.9m | $83.2m | ($126.6m) | ($38.1m) | ($4.7m) | ($1.7m) | — | |
| Other Income Expense | — | — | — | — | — | — | — | — | ($5.8m) | ($1.7m) | ($1.7m) | |
| Income (Loss) from Continuing Operations before Income Taxes, Domestic | — | — | — | — | — | — | — | — | — | ($9.0m) | ($88.3m) | |
| Pre-Tax Income | — | — | — | — | — | — | — | — | ($49.7m) | ($88.3m) | ($88.3m) | |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | — | — | ($401.1m) | ($208.6m) | $74.0m | ($366.4m) | ($363.4m) | ($206.4m) | ($49.7m) | ($88.3m) | ($88.3m) | |
| Loss from continuing operations before income tax expense | — | ($298.2m) | ($401.1m) | ($1.5b) | $483.1m | ($2.3b) | ($2.5b) | ($1.5b) | ($49.7m) | ($88.3m) | — | |
| Income Tax Expense (Benefit) | — | — | $1.7m | — | $1.9m | ($495k) | $101k | — | $0 | $0 | $0 | |
| Net loss | — | — | — | — | — | — | — | ($207.7m) | ($22.2m) | ($88.3m) | — | |
| Net loss attributable to NovaBridge | — | ($298.2m) | ($402.8m) | ($1.5b) | $470.9m | ($2.3b) | ($2.5b) | ($1.5b) | ($22.2m) | ($46.3m) | — | |
| Net Income From Continuing And Discontinued Operation | — | — | ($402.8m) | ($208.6m) | $72.2m | ($365.9m) | ($363.5m) | ($206.4m) | ($22.2m) | ($46.3m) | ($46.3m) | |
| Net Income Continuous Operations | — | — | — | — | — | — | — | — | ($49.7m) | ($88.3m) | ($88.3m) | |
| Net Income Discontinuous Operations | — | — | — | — | — | — | — | — | $27.5m | $0 | $0 | |
| Net loss per share from continuing operations attributable to NovaBridge - basic | — | — | — | — | — | — | ($1) | ($0) | ($0) | ($0) | — | |
| Net loss per share from continuing operations attributable to NovaBridge - diluted | — | — | — | — | — | — | ($1) | ($0) | ($0) | ($0) | — | |
| Net Income From Continuing Operation Net Minority Interest | — | — | — | — | — | — | — | — | ($49.7m) | ($46.3m) | ($46.3m) | |
| Net Income (Loss) Attributable to Noncontrolling Interest | — | — | — | — | — | — | — | — | — | ($42.1m) | ($46.3m) | |
| Net Income Including Noncontrolling Interests | — | — | — | — | — | — | — | — | ($22.2m) | ($88.3m) | ($88.3m) | |
| Income (Loss) from Continuing Operations, Per Basic Share | — | — | — | — | — | — | — | — | ($0) | ($0) | — | |
| Income (Loss) from Continuing Operations, Per Diluted Share | — | — | — | — | — | — | — | — | ($0) | ($0) | — | |
| Earnings Per Share, Basic | — | ($51.93) | ($61.70) | ($28.90) | $0.54 | ($2.09) | ($1.92) | ($1.08) | ($0.12) | ($0.21) | ($0.48) | |
| Earnings Per Share, Diluted | — | ($51.93) | ($61.70) | ($28.90) | $0.46 | ($2.09) | ($1.92) | ($1.08) | ($0.12) | ($0.21) | ($0.48) | |
| Weighted Average Number of Shares Outstanding, Basic | — | — | — | — | 134.2m | 174.7m | 189.8m | 191.4m | 186.7m | 220.3m | 95.8m | |
| Weighted Average Number of Shares Outstanding, Diluted | — | — | 6.5m | 7.4m | 157.2m | 174.7m | 189.8m | 191.4m | 186.7m | 220.3m | 95.8m | |
| Additional Financial Items | ||||||||||||
| Goodwill, Impairment Loss | — | — | — | — | — | — | $0 | $22.9m | $0 | $0 | $0 | |
| Impairment of goodwill | — | — | — | — | — | $0 | $0 | ($162.6m) | $0 | $0 | — | |
| Equity in loss of affiliates | — | — | — | $0 | ($108.6m) | ($367.9m) | ($437.5m) | ($80.0m) | ($1.0m) | — | — | |
| Loss from continuing operations | — | — | — | — | — | — | ($141.2m) | ($82.2m) | ($49.7m) | ($88.3m) | — | |
| Foreign currency translation adjustments, net of tax | — | $5.9m | $53.7m | $1.5m | ($120.9m) | ($135.7m) | $400.3m | $84.5m | $1.8m | ($6k) | — | |
| Comprehensive loss attributable to NovaBridge | — | ($292.3m) | ($349.1m) | ($1.4b) | $350.0m | ($2.5b) | ($2.1b) | ($1.4b) | ($28.6m) | ($38.1m) | — | |
| Diluted NI Availto Com Stockholders | — | — | — | — | — | — | — | — | ($22.2m) | ($46.3m) | ($46.3m) | |
| Earnings From Equity Interest | — | — | — | — | — | — | — | — | ($1.0m) | $0 | $0 | |
| Impairment Of Capital Assets | — | — | — | — | — | — | $0 | — | $1.2m | $0 | $0 | |
| Minority Interests | — | — | — | — | — | — | — | — | $0 | $42.1m | $42.1m | |
| Normalized EBITDA | — | — | — | — | — | — | — | — | ($45.1m) | ($91.7m) | ($93.4m) | |
| Normalized Income | — | — | — | — | — | — | — | — | ($44.3m) | ($44.5m) | ($44.5m) | |
| Other Gand A | — | — | — | — | — | — | — | — | $29.7m | $31.4m | — | |
| Reconciled Depreciation | — | — | — | — | — | — | — | — | $978k | $856k | $856k | |
| Selling General And Administration | — | — | — | — | — | — | — | — | $29.7m | $31.4m | — | |
| Special Income Charges | — | — | — | — | — | — | $0 | — | ($13.6m) | $0 | $0 | |
| Tax Effect Of Unusual Items | — | — | — | — | — | — | — | $0 | $0 | $0 | $0 | |
| Tax Provision | — | — | — | — | — | — | — | $0 | $0 | $0 | $0 | |
| Tax Rate For Calcs | — | — | — | — | — | — | $0 | $0 | $0 | $0 | $0 | |
| Administrative expenses (including amounts with related parties of $2,600, $239, and $0, respectively - Note 17) | — | ($25.4m) | ($66.4m) | ($654.6m) | ($402.4m) | ($899.9m) | ($815.8m) | ($453.0m) | ($29.7m) | ($31.4m) | — | |
| Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent | — | — | ($438.6m) | ($210.4m) | $23.8m | ($325.0m) | ($285.5m) | ($197.0m) | ($49.7m) | ($46.3m) | — | |
| Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest | — | — | — | — | — | — | — | — | — | ($88.3m) | — | |
| Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest | — | — | — | — | — | — | — | — | $27.5m | $0 | — | |
| Total other comprehensive loss | — | — | — | — | — | — | — | ($202.1m) | ($28.6m) | ($80.2m) | — | |
| Total Unusual Items | — | — | — | — | — | — | — | — | ($5.4m) | ($1.8m) | ($1.8m) | |
| Total Expenses | — | — | — | — | — | — | ($51.5m) | ($72.6m) | ($51.4m) | ($94.3m) | $94.3m |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.